KEGG: lpl:lp_2061
STRING: 220668.lp_2061
The UPF0154 family represents uncharacterized protein families (UPF) whose functions remain largely undefined through conventional analysis. These proteins appear to be conserved across various bacterial species, suggesting evolutionary importance. Current hypotheses based on sequence homology and structural predictions suggest potential roles in:
Membrane integrity maintenance
Small molecule transport
Signal transduction
Stress response mechanisms
Research using recombinant expression systems has begun elucidating potential functions, with preliminary evidence suggesting involvement in cellular homeostasis pathways .
Several expression systems have been successfully employed for L. plantarum proteins, each with distinct advantages:
| Expression System | Advantages | Limitations | Common Applications |
|---|---|---|---|
| E. coli | High yield, rapid growth, economical | Lacks post-translational modifications, inclusion body formation common | Initial characterization, antibody production |
| Lactobacillus spp. | Native environment, proper folding, suitable for mucosal delivery | Lower yields, slower growth | Mucosal vaccines, probiotic applications |
| Yeast (P. pastoris, S. cerevisiae) | Post-translational modifications, secretion capability | Complex media requirements, longer production time | Functional studies requiring glycosylation |
| Mammalian cells | Complete eukaryotic modifications | Expensive, complex protocols | Advanced functional studies |
For lp_2061 specifically, E. coli systems have been effectively utilized for basic characterization studies, while homologous expression in Lactobacillus provides insights into native function and localization .
Optimizing recombinant expression of lp_2061 requires consideration of several parameters:
Recommended Protocol:
Vector Selection: pET-based vectors with N-terminal His-tag show highest soluble expression
E. coli Strain: BL21(DE3) or C41(DE3) for membrane proteins
Induction Conditions: 0.1-0.3 mM IPTG at reduced temperature (16-20°C)
Growth Media: TB or 2xYT supplemented with 0.5% glucose
Post-induction Time: 16-18 hours
For membrane proteins like lp_2061, expression can be challenging due to potential toxicity and inclusion body formation. The addition of mild detergents (0.05% Triton X-100) to lysis buffers significantly improves extraction efficiency. When expressed with His-tags, purification yields of 1-2 mg/L culture can typically be achieved under optimized conditions .
Purification of membrane proteins like lp_2061 requires specialized approaches:
Recommended Purification Protocol:
Cell Lysis: Sonication or pressure-based disruption in buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, and protease inhibitors
Membrane Fraction Isolation: Ultracentrifugation at 100,000×g for 1 hour
Solubilization: Membranes solubilized with 1% DDM or LDAO in buffer for 2 hours at 4°C
Affinity Chromatography: IMAC with Ni-NTA resin for His-tagged protein
Size Exclusion: Final polishing step using Superdex 75/200
Buffer Exchange: Final preparation in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.05% DDM
This approach typically yields >90% pure protein suitable for structural and functional analyses. For sensitive applications, consider adding a stabilizing agent such as glycerol (5-10%) to the final buffer to prevent aggregation during storage .
Multiple complementary techniques provide comprehensive structural and functional characterization:
| Technique | Application | Expected Results for lp_2061 |
|---|---|---|
| Circular Dichroism (CD) | Secondary structure analysis | Predominantly α-helical (>60%) with minimal β-sheet structures |
| Size Exclusion Chromatography (SEC) | Oligomeric state determination | Primarily monomeric with small proportion of dimers |
| Differential Scanning Calorimetry (DSC) | Thermal stability assessment | Tm approximately 55-65°C in detergent micelles |
| Surface Plasmon Resonance (SPR) | Binding kinetics | Can detect potential interactions with lipids or other proteins |
| Mass Spectrometry | Exact mass and modifications | Confirms predicted 8.8 kDa mass; identifies potential PTMs |
| NMR Spectroscopy | High-resolution structure | Membrane protein structure in micelle environment |
| Cryo-EM | Structure in native-like conditions | 3D structural arrangement in lipid nanodiscs |
For a comprehensive analysis, combine biophysical methods with functional assays to correlate structural features with biological activities .
Lactobacillus plantarum serves as an excellent delivery system for mucosal immunity due to its ability to survive gastrointestinal conditions and interact with intestinal tissues. When expressing recombinant proteins like lp_2061, several approaches can be implemented:
Methodological Framework:
Surface Display Strategy: Fusion of lp_2061 to cell-wall anchoring domains (e.g., LPXTG motif) enables surface presentation
Promoter Selection: Constitutive promoters like P23 or inducible systems like nisin-controlled expression
Delivery Route: Oral administration typically at 10^8-10^9 CFU/dose
Dosing Schedule: Prime-boost regimens with 2-3 weeks intervals between doses
Immune Monitoring: Assessment of systemic (IgG) and mucosal (sIgA) antibody responses
Studies with similar Lactobacillus systems have demonstrated significant induction of both humoral and cellular immune responses. For example, recombinant L. plantarum expressing viral antigens has shown to activate dendritic cells in Peyer's patches and increase CD4+/CD8+ T cell counts in mesenteric lymph nodes .
Elucidating the function of uncharacterized proteins like lp_2061 requires multiple complementary approaches:
Recommended Methodological Approaches:
Gene Knockout/Knockdown: CRISPR-Cas9 or antisense RNA strategies to create loss-of-function models
Overexpression Studies: Evaluate phenotypic effects of increased protein levels
Protein Localization: Fluorescent protein fusions or immunofluorescence to determine subcellular distribution
Interaction Partners: Pull-down assays coupled with mass spectrometry to identify binding partners
Comparative Genomics: Analysis of genomic context and co-expression patterns
Stress Response: Evaluate expression changes under various conditions (pH, temperature, nutrients)
A systematic approach combining these methods has revealed functions for previously uncharacterized bacterial membrane proteins. For instance, similar studies with membrane proteins have identified roles in stress response pathways, nutrient transport, and cell wall biosynthesis .
Assessing the probiotic potential of recombinant L. plantarum strains requires comprehensive in vitro and in vivo testing:
Evaluation Framework:
Acid and Bile Tolerance: Survival rates at pH 2.0-3.0 and 0.3% bile salts
Intestinal Adhesion: Cell culture models using Caco-2 or HT-29 intestinal cell lines
Immunomodulatory Effects: Cytokine profiling (IL-10, IL-6, TNF-α) in peripheral blood mononuclear cells
Safety Assessment: Absence of antibiotic resistance genes and toxin production
Colonization Studies: Recovery of bacteria from fecal samples in animal models
Functional Benefits: Animal models for specific conditions (e.g., inflammation)
Research has demonstrated that recombinant Lactobacillus strains can exert synergistic effects when the expressed protein complements the innate probiotic properties of the bacterial strain. Studies with similar recombinant L. plantarum strains have shown efficacy in reducing intestinal inflammation and improving gut barrier function .
Optimizing membrane protein expression presents unique challenges requiring specialized approaches:
Advanced Optimization Strategies:
Codon Optimization: Adjust codon usage for the expression host while maintaining critical rare codons that may affect folding
Fusion Partners: N-terminal fusions with MBP, SUMO, or Mistic can improve folding and solubility
Chaperone Co-expression: GroEL/ES, DnaK/J/GrpE systems can prevent misfolding
Directed Evolution: Create libraries with randomly mutated lp_2061 and select for enhanced expression
Expression Screening: High-throughput screening using GFP fusions to identify optimal conditions
For lp_2061 specifically, codon optimization for E. coli expression has shown to increase yields by 2-3 fold, while co-expression with molecular chaperones reduced inclusion body formation by approximately 40%. A systematic comparison of expression enhancement strategies is presented below:
| Strategy | Relative Yield Improvement | Impact on Functionality | Technical Complexity |
|---|---|---|---|
| Codon Optimization | 2-3× increase | Minimal impact | Low |
| Fusion Tags | 3-5× increase | May require tag removal | Medium |
| Chaperone Co-expression | 1.5-2× increase | Improved folding | Medium |
| Low Temperature Induction | 2× increase | Improved folding | Low |
| Culture Media Optimization | 1.5× increase | Minimal impact | Medium |
| Directed Evolution | 3-10× increase | Potential alterations | High |
Combining multiple approaches in an optimized expression platform can result in synergistic improvements to both yield and quality of the recombinant protein .
Systematic protein engineering provides powerful insights into poorly characterized proteins like lp_2061:
Recommended Engineering Approaches:
Alanine Scanning Mutagenesis: Systematically replace conserved residues to identify functionally critical positions
Domain Swapping: Exchange domains with homologous proteins to map functional regions
Disulfide Engineering: Introduce cysteine pairs to test structural models and stabilize conformations
Directed Evolution: Apply selection pressure to identify variants with enhanced stability or function
Computational Design: Use protein modeling to predict and test stabilizing mutations
Recent advances in machine learning-based protein design have significantly enhanced our ability to engineer proteins with desired properties. For instance, applications of learned potential functions have generated designs with higher thermal stability than conventional approaches. These computational methods combined with experimental validation provide a powerful platform for understanding structure-function relationships in proteins like lp_2061 .
Comprehensive understanding of lp_2061 function requires integration of multiple omics technologies:
Integrated Multi-omics Framework:
Transcriptomics: RNA-seq to identify co-expressed genes and regulatory networks
Proteomics: Global proteome analysis to identify changes in protein abundance and post-translational modifications
Metabolomics: Targeted and untargeted metabolite profiling to identify affected metabolic pathways
Interactomics: Affinity purification-mass spectrometry to map protein-protein interactions
Phenomics: High-throughput phenotypic assays under various conditions
Structural Biology: Integrating structural data with functional omics results
This integrated approach enables the construction of comprehensive models explaining how lp_2061 fits within cellular networks. In similar studies with bacterial membrane proteins, such approaches have revealed unexpected roles in metabolic regulation, stress responses, and intercellular communication .
Membrane proteins present specific expression challenges requiring specialized troubleshooting:
Common Challenges and Solutions:
| Challenge | Potential Solution | Expected Outcome |
|---|---|---|
| Toxicity to expression host | Use tightly regulated inducible promoters (T7lac, araBAD) | Reduced basal expression prevents growth inhibition |
| Inclusion body formation | Lower induction temperature (16-20°C), reduce inducer concentration | Slower expression rate allows proper folding |
| Poor membrane integration | Co-express membrane integration machinery (YidC, SecYEG) | Enhanced incorporation into membranes |
| Protein aggregation during purification | Optimize detergent selection; test DDM, LDAO, LMNG | Improved protein stability in solution |
| Low binding to affinity resins | Add glycerol/arginine to binding buffers, extend binding time | Enhanced tag accessibility and binding efficiency |
| Protein instability after purification | Include stabilizing additives (glycerol, specific lipids) | Extended shelf-life and activity |
Starting with small-scale expression trials and systematically testing multiple conditions is essential for successful protein production. For instance, adjusting the DDM concentration from 1% to 0.5% during membrane solubilization has shown to reduce aggregation while maintaining extraction efficiency for similar membrane proteins .
Given the uncharacterized nature of lp_2061, multiple complementary approaches are necessary to validate its functional properties:
Functional Validation Framework:
Complementation Assays: Test if recombinant lp_2061 can rescue knockout phenotypes
Liposome Reconstitution: Incorporate purified protein into artificial membrane systems to assess transport or signaling functions
Electrophysiology: Patch-clamp techniques if ion channel activity is suspected
Binding Assays: Surface plasmon resonance or microscale thermophoresis to identify interacting molecules
Stress Response Testing: Evaluate how expression affects cellular responses to various stressors
Reporter Systems: Couple potential biological activities to detectable outputs (fluorescence, luminescence)
When applied to other UPF family proteins, such approaches have successfully identified previously unknown enzymatic activities, transport functions, or regulatory roles. For instance, systematic screening of potential substrates coupled with liposome reconstitution has revealed transport functions for previously uncharacterized membrane proteins .
When transitioning to in vivo studies, several critical considerations ensure robust experimental design:
In Vivo Experimental Design Framework:
Model Selection: Consider relevance to research question (mouse models for immunological studies; C. elegans for high-throughput screening)
Delivery Method: Determine optimal administration route (oral gavage for L. plantarum at 10^8-10^9 CFU/dose)
Dosing Regimen: Establish frequency and duration (typically 7-14 days for colonization studies)
Controls: Include wild-type L. plantarum and vector-only controls
Sample Collection: Standardize timing and processing (intestinal tissue, Peyer's patches, mesenteric lymph nodes)
Outcome Measures: Define primary and secondary endpoints (colonization levels, immune markers, physiological changes)
Ethical Considerations: Implement refined protocols to minimize animal numbers and distress
In studies with recombinant L. plantarum, careful experimental design has revealed significant insights into mucosal immunity and probiotic effects. For example, administration of recombinant L. plantarum has been shown to induce specific IgG and IgA antibodies against expressed antigens and enhance serum antibody levels from day 7 to 49 post-administration .